Roche bets $4.3 billion on Spark in gene therapy move

Roche Holding AG is to buy U.S.-based Spark Therapeutics in a $4.3 billion deal that will give the Swiss drugmaker a foothold in gene therapy.


from Reuters: Top News https://ift.tt/2ICTgHV Roche Holding AG is to buy U.S.-based Spark Therapeutics in a $4.3 billion deal that will give the Swiss drugmaker a foothold in gene therapy.

Related Posts:

0 comments:

Post a Comment

Sample Text

Blog Archive

Powered by Blogger.

Social Widget